Circu- lation 2004;110:975 81. 303. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not trans- plant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 2007; 50:741 7. 304. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous- ow left ventricular assist device. N Engl J Med 2009;361:2241 51. 305. Mehra MR, Kobashigawa J, Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates 2006. J Heart Lung Transplant 2006;25:1024 42. 306. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA 2002;287:628 40. 307. Metra M, Torp-Pedersen C, Cleland JG, et al. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Eur J Heart Fail 2007;9:901 9. 308. Fonarow GC, Abraham WT, Albert NM, et al. In uence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: ndings from the OPTIMIZE-HF program. J Am Coll Cardiol 2008;52:190 9. 309. Butler J, Young JB, Abraham WT, et al. Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 2006;47: 2462 9. 310. Maisel AS, Peacock WF, McMullin N, et al. Timing of immunore- active B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. J Am Coll Cardiol 2008;52: 534 40. 311. Peacock WF, Fonarow GC, Emerman CL, et al. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology 2007;107:44 51. 312. Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure. 